Company Overview and News
Costco Wholesale Corporation (NASDAQ:COST) survived the retail apocalypse relatively unscathed, but should BJ’s IPO have Costco — and COST stockholders — spooked?
In February, I published the DCF model of Amazon (AMZN), which, at the conservative forecast parameters, indicated that the company's share price was balanced. The comments under that article included some criticism regarding Amazon's margin forecast for the next 10 years. Some people claimed that I underestimated the company's potential. Others, on the contrary, told my margin forecast was overly optimistic.
In my view, investors would be wise to buy GameStop at these levels. The dividend yield is very generous and is well covered by free cash flow.
One thing that investors can't say about Walmart (NYSE:WMT) is that there has been a clear lack of effort to transform the company. Amazon (NASDAQ:AMZN) came on the scene many years ago and disrupted the whole sector. Walmart, for a few quarters some years back, found itself standing still as Amazon raced ahead with its market share gains.
Lowe’s Companies Inc. (NYSE: LOW) may be among the largest home improvement retailers in America, often ranked just behind Home Depot Inc. (NYSE: HD). New CEO Marvin Ellison, who helped wreck J.C. Penney Co. Inc. (NYSE: JCP), faces an uphill battle Lowe’s cannot win.
Walmart announced that it would pay $16 billion to acquire a 77% stake in Flipkart, an Indian online retail firm.
Amazon.com, Inc. (NASDAQ:AMZN). The name itself excites those who own a stake in the company, yet that same name can strike fear into the hearts of owners of rival e-commerce stocks. Amazon gets what Amazon wants, and will roll over anyone or anything that stands in its way.
Leading the Apple Inc. (NASDAQ:AAPL) rumor mill today is news of a cheaper HomePod on the way. Today, we’ll look at that and other Apple Rumors for Monday.
Plain and simple: the term is outdated. A lot of large-cap familiar names are still called “blue-chip stock” when they are nothing of the kind. If you can’t rid the term “blue-chip stock” from your lexicon, then it should at least apply to a whole new stream of companies.
Hawaii’s Kilauea volcano has erupted, sending ash clouds 30,000 feet into the sky. There’s a volcano going gangster on our 50th state, and nobody seems to care. Hundred-year weather events seem to be happening every hundred days. Similarly, ridiculously stupid actions or words from our leaders used to get our attention, but now the high-velocity vomiting that DC sprays across the airwaves has numbed us.
Procter & Gamble Co. (NYSE: PG) posted a slim share price gain of 0.1% last week, not enough to shake off the company’s ranking as the worst performing Dow Jones industrial stock of this year. So far in 2018, the shares have lost 20.1%. This is P&G’s fifth consecutive week as the Dow’s worst stock for the year.
Why I see this having significant potential for disappointing results in the core business associated with the deal.
Kroger Co (NYSE:KR) will be the U.S. home for robotic logistics technology from Ocado Group PLC (OTCMKTS:OCDGF), an online grocer in the U.K., with a 5% stake costing $247 million, valuing the smaller company at nearly $5 billion.
The hottest ticket in town this week was in New York City. But unlike any top-tier event, you were invited … if you could afford it.
Opening Amazon Go stores at downtown locations across the U.S. may not significantly impact its retail revenue;
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
as of ET